tiprankstipranks
Trending News
More News >
Otc Markets Group (OTCM)
:OTCM
US Market
Advertisement

OTC Markets Group (OTCM) AI Stock Analysis

Compare
138 Followers

Top Page

OT

OTC Markets Group

(OTC:OTCM)

Rating:73Outperform
Price Target:
$67.00
▲(16.70%Upside)
OTC Markets Group's strong financial performance, characterized by robust profitability and cash flow, is the primary driver of its overall score. The technical analysis indicates bullish momentum but caution due to overbought signals. The valuation is moderately attractive, offering some income potential.

OTC Markets Group (OTCM) vs. SPDR S&P 500 ETF (SPY)

OTC Markets Group Business Overview & Revenue Model

Company DescriptionOTC Markets Group Inc. engages in the financial market business in the United States and internationally. It offers OTC Link Alternative Trading System, an interdealer quotation and trade messaging system; OTC Dealer, a real-time, front-end application that provides consolidated quotation, trading, and information system to attract and access market liquidity; OTC FIX, which uses the industry standard FIX protocol for quote submission, trading, and routing of execution reports; and OTC Link Electronic Communication Networks (ECN) and OTC Link National Quotation Bureau (NQB) that acts as the executing party on an agency basis in relation to transactions executed on platforms. The company also provides OTC Markets Real-Time Data products that provides quote, trade, and reference data for OTC Link ATS; OTC Markets Pricing and Reference Data products for detailed view into the securities and issuers within the OTC market; and compliance data products. In addition, it offers OTC Disclosure & News Service for publishing and distributing data, news, and financials; Real-Time Level 2 Quote Display, a service that companies sponsor to provide their investors with access to real-time level 2 quotes on otcmarkets.com and the issuer's Website; Blue Sky Monitoring Service for analysis, review, and guidance about a company's compliance with the United States securities laws; and Virtual Investor Conferences, which allows issuers to communicate and engages with investors, as well as operates the OTCQX Best Market, OTCQB Venture Market, and Pink Open Market. Further, it offers software, and risk and performance analytics tools for the banking and finance industries; online capital raising solutions; and OTCIQ, an investor relations portal. The company was formerly known as Pink OTC Markets Inc. and changed its name to OTC Markets Group Inc. in January 2011. OTC Markets Group Inc. was founded in 1904 and is headquartered in New York, New York.
How the Company Makes MoneyOTC Markets Group generates revenue primarily through fees and services associated with the trading and listing of securities. The company earns income from market data licensing, where it charges fees to distribute its market data to financial institutions, investors, and other market participants. Additionally, OTC Markets Group collects fees from companies that list their securities on its platforms, with different fee structures depending on the market tier (OTCQX, OTCQB, or Pink). The company also derives revenue from providing issuer services, such as corporate communications and compliance tools, which help listed companies maintain visibility and adhere to market regulations. Partnerships with broker-dealers and financial service providers further enhance its service offerings and contribute to its overall revenue.

OTC Markets Group Earnings Call Summary

Earnings Call Date:May 07, 2025
(Q4-2024)
|
% Change Since: 16.17%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted a record revenue achievement and promising initiatives like overnight trading, but it also pointed out several challenges such as declining corporate services revenue and increased operating expenses. While there is strong growth in OTC Link and a positive outlook on regulatory engagement, the subscriber decline and flat market data revenue balance the sentiment.
Q4-2024 Updates
Positive Updates
Record Revenue Achievement
OTC Markets Group achieved over $111 million in annual revenues for the first time, marking a 1% increase compared to 2023.
Growth in OTC Link Business
OTC Link's revenues increased by 14% year-over-year, driven by a 21% increase in revenues from OTC Link ECN and NQB, and a 16% increase in revenues from ATS messages.
Overnight Trading Initiative
OTC Markets is launching OTC Overnight and Moon ATS for trading in OTC and exchange-listed securities, providing access during Asian market hours and European market open.
Dividend Declaration
The Board of Directors declared a quarterly dividend of $0.18 per share, reflecting the company's commitment to shareholder returns.
Positive Retention Rates
Retention rate for OTCQX subscription period beginning January 1, 2025, achieved a 96% retention rate, up from 93% in the previous year.
Negative Updates
Decrease in Corporate Services Revenue
Corporate services revenues decreased by 4% for the year, with a flat revenue from OTCQX and decreases of 5% and 7% in OTCQB and DNS revenues.
Subscriber Decline in Corporate Services
OTCQX and OTCQB saw declines in the number of companies, with OTCQX down 6% and OTCQB down 8% at the end of the quarter.
Flat Market Data Licensing Revenue
Market data licensing business saw only a modest 1% growth year-over-year, with a decline of 10% in non-pro user revenue.
Increased Operating Expenses
Operating expenses increased by 1% for the year, driven by a 7% increase in compensation and benefits and a 16% increase in IT infrastructure costs.
Company Guidance
The guidance provided during the OTC Markets Group Fourth Quarter and Full Year 2024 Earnings Conference Call highlighted several key metrics and strategic priorities. The company reported a slight increase in both gross and net revenues, achieving over $111 million in annual revenues for the first time, with a notable 33% growth in OTC Link's revenues. The market data licensing business remained flat, while corporate services saw a 6% decrease in revenue. Operating expenses grew by approximately 1%, and the company maintained a 1% increase in adjusted EBITDA, amounting to $41.3 million. In 2025, the company plans to focus on two major projects: the launch of OTC Overnight, enabling trading from 8 pm to 4 am Eastern Time, and the development of the OTCID basic reporting market, set to launch on July 1, 2025. Additionally, the company declared a quarterly dividend of $0.18 per share, demonstrating its commitment to shareholder returns.

OTC Markets Group Financial Statement Overview

Summary
OTC Markets Group exhibits strong financial health with robust profitability, a healthy balance sheet, and solid cash flow performance. The income statement shows a strong net profit margin of 27.0% and efficient operations with stable revenue growth. The balance sheet is favorable with a manageable debt-to-equity ratio of 0.35, and cash flow metrics highlight efficient cash generation and stability.
Income Statement
85
Very Positive
OTC Markets Group's income statement shows strong profitability with a consistent Gross Profit Margin of 56.4% in 2024. The Net Profit Margin is robust at 27.0%, indicating effective cost management. Revenue growth has been stable, with a slight increase of 0.1% in the latest year. EBIT and EBITDA margins are solid at 31.8% and 34.5%, respectively, reflecting efficient operations.
Balance Sheet
78
Positive
The balance sheet displays a favorable equity position with a Debt-to-Equity Ratio of 0.35, suggesting manageable leverage. The Return on Equity is impressive at 76.6%, driven by strong net income. The Equity Ratio stands at 39.4%, indicating a balanced capital structure with room for future growth.
Cash Flow
80
Positive
Cash flow performance is strong with a consistent Operating Cash Flow to Net Income Ratio of 1.20, highlighting efficient cash generation. The Free Cash Flow increased by 0.3% year-over-year, demonstrating stable cash flow growth. The Free Cash Flow to Net Income Ratio of 1.15 underscores the company's ability to generate cash beyond its net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue108.54M101.23M101.13M105.15M99.91M68.42M
Gross Profit56.13M57.11M49.91M58.62M56.59M36.50M
EBITDA35.66M34.89M34.99M38.91M39.81M23.20M
Net Income27.41M27.36M27.05M30.81M30.48M18.27M
Balance Sheet
Total Assets86.05M90.74M90.53M89.62M82.25M64.81M
Cash, Cash Equivalents and Short-Term Investments32.89M39.03M37.72M37.37M50.39M33.73M
Total Debt12.07M12.47M13.95M15.24M16.46M16.29M
Total Liabilities47.63M55.02M58.30M59.81M57.30M45.26M
Stockholders Equity38.42M35.72M32.23M29.80M24.95M19.55M
Cash Flow
Free Cash Flow31.87M31.57M31.47M32.24M45.06M24.98M
Operating Cash Flow32.76M32.87M33.04M33.68M46.46M26.01M
Investing Cash Flow-1.13M-2.19M-5.19M-16.39M-1.40M-1.03M
Financing Cash Flow-29.95M-30.24M-31.10M-30.31M-28.40M-19.46M

OTC Markets Group Technical Analysis

Technical Analysis Sentiment
Positive
Last Price57.41
Price Trends
50DMA
51.66
Positive
100DMA
49.64
Positive
200DMA
49.97
Positive
Market Momentum
MACD
2.13
Negative
RSI
61.52
Neutral
STOCH
58.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OTCM, the sentiment is Positive. The current price of 57.41 is above the 20-day moving average (MA) of 54.93, above the 50-day MA of 51.66, and above the 200-day MA of 49.97, indicating a bullish trend. The MACD of 2.13 indicates Negative momentum. The RSI at 61.52 is Neutral, neither overbought nor oversold. The STOCH value of 58.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OTCM.

OTC Markets Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
$51.33B40.5411.43%1.21%25.89%16.37%
80
Outperform
$24.61B30.8118.93%1.07%15.76%1.97%
CMCME
79
Outperform
$99.13B27.6513.40%1.82%11.72%13.31%
ICICE
79
Outperform
$103.55B37.3810.27%1.06%13.25%10.82%
73
Outperform
$687.49M25.3273.60%1.25%4.00%-0.07%
67
Neutral
$16.77B11.739.77%3.75%12.07%-8.28%
DNDNB
62
Neutral
$4.07B-0.64%2.19%2.52%42.27%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OTCM
OTC Markets Group
57.41
11.37
24.70%
CBOE
Cboe Global Markets
235.01
64.51
37.84%
CME
CME Group
275.08
86.57
45.92%
ICE
Intercontinental Exchange
180.51
34.33
23.48%
NDAQ
Nasdaq
89.41
27.21
43.75%
DNB
Dun & Bradstreet Holdings
9.11
-0.68
-6.95%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 09, 2025